Vertex Pharmaceuticals Incorporated VRTX
526.19
3.81
0.73%
as of 25 Sep
- Market cap
- $132.3B
- P/E
- 30.4×
Follow VRTX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
22.31% | 22.54% | 24.20% | 23.54% | |
| 15.60% | 16.41% | 17.58% | 17.12% | ||
ROIC |
22.62% | 21.63% | 24.15% | 24.09% | |
Return on Tangible Assets |
48.87% | 44.62% | 45.87% | 42.89% | |
Average Days of Receivables |
60.60 | 62.43 | 59.63 | 61.89 | |
Free Cash Flow per Share |
13.06 | 12.49 | 14.60 | 14.96 | |
Free Cash Flow |
3,337.20 | 3,193.80 | 3,710.30 | 3,796.10 | |
Capital Expenditures |
(380.80) | (437.60) | (530.30) | (496.80) | |
Piotroski F-Score |
7.00 | 7.00 | 7.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
15.75% | 14.37% | 15.94% | 15.28% | |
Accounts Receivable Turnover |
6.34 | 6.55 | 6.43 | 6.25 | |
Accounts Payable Turnover |
3.94 | 3.78 | 3.60 | 4.04 | |
Inventory Turnover |
1.19 | 1.14 | 1.08 | 1.08 | |
Average Days of Payables |
95.36 | 102.05 | 106.24 | 88.93 | |
Days of Inventory on Hand |
369.11 | 372.85 | 383.59 | 365.48 | |
Tax Rate |
(0.17) | (0.15) | (0.16) | (0.16) | |
Research and Development Expense of Revenue |
33.56% | 32.58% | 31.85% | 31.04% | |
Selling, General and Administrative Expense of Revenue |
14.02% | 14.61% | 15.14% | 15.95% | |
Share Based Compensation of Revenue |
5.94% | 5.72% | 5.62% | 5.47% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.01 | 0.92 | 0.98 | 0.97 | |
Depreciation/Fixed assets |
0.14 | 0.14 | 0.14 | 0.13 | |
Capex/Depreciation |
(1.90) | (2.09) | (2.44) | (2.24) | |
Revenue per Share |
45.87 | 46.94 | 48.08 | 49.61 | |
Operating CF per Share |
14.55 | 14.20 | 16.69 | 16.92 | |
Capex per Share |
(1.49) | (1.71) | (2.09) | (1.96) | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.04 | |
Net Profit Margin |
31.35% | 32.94% | 35.51% | 35.00% |
Columns are period end dates